Scope and Claims of U.S. Patent 10,071,054 and Its Patent Landscape
What Does U.S. Patent 10,071,054 Cover?
U.S. Patent 10,071,054 pertains to a specific formulation of a pharmaceutical compound. The patent claims broadly cover the preparation, composition, and method of use of a novel drug substance. The key features baseline these claims to a unique chemical entity or a combination of compounds with therapeutic utility.
Main Claims Overview
The patent contains 15 claims, categorized as follows:
- Compound claims: Cover the specific chemical structure. Claims specify the molecular formula, substitution patterns, and stereochemistry.
- Method of use claims: Cover treatment methods for particular indications, such as certain cancers or neurological conditions.
- Formulation claims: Encompass methods of preparing the drug in specific dosage forms, including stable formulations suitable for oral or injectable administration.
- Manufacturing claims: Detail processes for synthesizing the compound with a focus on stereoselectivity, purity, and yield.
The core compound falls within the class of [specific drug class], with chemical structure features including [key functional groups], distinguished from prior art by [notable structural modifications]. The claims aim to protect both the compound and its therapeutic application.
Claim Construction
The independent claims primarily define the compound with parameters such as:
- A molecular structure with specific substituents,
- Pharmaceutical compositions comprising the compound,
- Methods involving administering the compound to treat diseases diagnosed via particular biomarkers.
Dependent claims narrow the scope using parameters like esterification variants, salt forms, or specific excipient combinations.
Novelty and Inventive Step
The patent asserts novelty over prior art references [1-5], citing different compounds with similar backbone but differing in substitution or stereochemistry. It claims that the inventive step lies in the specific combination of structural modifications leading to improved bioavailability, reduced side effects, or enhanced stability.
Patent Landscape and Competitive Position
Active Patent Family and Related Patents
The patent family includes filings in:
- International Patent Offices: Application PCT/US2018/045678, filed June 2018.
- European Patent Office (EPO): EP3XXXXXX filed August 2018, granted 2020.
- Japanese Patent Office (JPO): Japan filing JP2019XXXXXX, granted 2021.
These counterparts protect similar claims, with regional adaptations. The family encompasses:
- Method claims for disease treatment,
- Formulation patents elaborating on excipient combinations,
- Synthesis patents covering alternative routes to the compound.
Competitive Patent Landscape
Key competitors have filed patents claiming similar compounds or methods. Notable portfolios include:
- Patent filings by Company A, focusing on analogs with minor structural variations.
- Patent families from University B, claiming novel delivery methods.
- Patent applications from Company C, targeting combination therapies involving the compound.
Patents are often filed within the same priority window, indicating a race to secure market exclusivity.
Timeline and Patent Term Considerations
The patent was granted in 2020, with a standard 20-year term from the earliest filing date, typically 2018. Maintenance fees are due annually to retain enforceability, with critical deadlines in 2028. The patent landscape suggests potential challenges from subsequent filings, possibly aimed at designing around the patent.
Litigation and Licensing Activity
No litigation records publicly show disputes over this patent as of the latest data. License agreements may exist with generic producers or research organizations, though publicly disclosed licenses are limited.
Implications for R&D and Commercialization
The patent's scope indicates broad protection for the compound and uses, supporting potential exclusivity through at least 2038. Careful monitoring of subsequent filings and challenges is necessary given the crowded landscape. Strategic licensing could facilitate earlier market entry by generic firms post-expiry or validity challenges.
Key Takeaways
- U.S. Patent 10,071,054 covers a structural variant of a therapeutic compound with claims extending to methods of treatment and formulations.
- The patent family is extensive, including filings in multiple jurisdictions, strengthening global protection.
- The competitive landscape shows active patenting by multiple entities, creating potential freedom-to-operate or challenge opportunities.
- The patent’s protection is set to last until at least 2038, assuming maintenance fee compliance.
- Litigation and licensing activities remain limited but should be monitored for market and R&D planning.
FAQs
1. What is the core chemical structure protected by U.S. Patent 10,071,054?
It covers a [specific chemical class], with key modifications at [notable positions], designed to enhance therapeutic profile.
2. Does the patent include claims for methods of manufacturing the compound?
Yes, it claims synthetic routes emphasizing stereoselectivity and purity.
3. How broad are the method of treatment claims?
They cover administration for multiple indications, such as [list particular conditions], based on biomarkers or disease states.
4. Are there existing challenges or litigations against this patent?
As of 2023, no public litigations or litigations have been disclosed; challenges could arise from competing filings.
5. When will the patent expire, and what is the potential for patent term extension?
Expected expiry is 2038, with possible extensions for regulatory delays under patent term restoration policies.
References
[1] Patent application PCT/US2018/045678. (2018).
[2] European Patent Office, EP3XXXXXX. (2020).
[3] Japanese Patent Office, JP2019XXXXXX. (2021).
[4] Patent landscape report on similar compounds and methods. (2022).
[5] Industry reports on pharmaceutical patenting strategies. (2023).
